1,516
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Design and evaluation of glutathione responsive glycosylated camptothecin nanosupramolecular prodrug

, , , , &
Pages 1903-1914 | Received 06 Aug 2021, Accepted 30 Aug 2021, Published online: 14 Sep 2021

References

  • Cai K, He X, Song ZY, et al. (2015). Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency. J Am Chem Soc 137:3458–61.
  • Cheetham AG, Ou YC, Zhang PC, et al. (2014). Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles. Chem Commun 50:6039–42.
  • Chen Z, Li WH, Shi LW, et al. (2020). Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy. Eur J Pharm Biopharm 156:143–54.
  • Ding Y, Wang YZ, Zhou JP, et al. (2014). Direct cytosolic siRNA delivery by reconstituted high density lipoprotein for target-specific therapy of tumor angiogenesis. Biomaterials 35:7214.
  • D'Souza AA, Devarajan PV. (2015). Asialoglycoprotein receptor mediated hepatocyte targeting – strategies and applications. J Control Release 203:126–39.
  • Hu MX, Huang P, Wang Y, et al. (2015). Synergistic combination chemotherapy of camptothecin and floxuridine through self-assembly of amphiphilic drug-drug conjugate. Bioconjug Chem 26:2497–506.
  • Huang P, Wang DL, Su Y, et al. (2014). Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J Am Chem Soc 136:11748–56.
  • Jin YL, Huang YY, Yang H, et al. (2015). A peptide-based pH-sensitive drug delivery system for targeted ablation of cancer cells. Chem Commun 51:14454–7.
  • Li Y, Huang G, Diakur J, et al. (2008). Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development. Curr Drug Deliv 5:299–302.
  • Lock LL, Reyes C, Zhang PC, et al. (2016). Tuning cellular uptake of molecular probes by rational design of their assembly into supramolecular nanoprobes. J Am Chem Soc 138:3533–40.
  • Ma PK, Sun Y, Chen JH, et al. (2018). Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate. Drug Deliv 25:153–65.
  • Mou QB, Ma Y, Zhu XY, et al. (2016). A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy. J Control Release 230:34–44.
  • Qin S, Zhang A, Cheng S, et al. (2017). Drug self-delivery systems for cancer therapy. Biomaterials 112:234–47.
  • Ren CH, Wang HM, Mao D, et al. (2015). When molecular probes meet self-assembly: an enhanced quenching effect. Angew Chem Int Ed Engl 54:4823–7.
  • Takaoka Y, Nishikawa Y, Hashimoto Y, et al. (2015). Ligand-directed dibromophenyl benzoate chemistry for rapid and selective acylation of intracellular natural proteins. Chem Sci 6:3217–24.
  • Tan XY, Li BB, Lu XG, et al. (2015). Light-triggered, self-immolative nucleic acid-drug nanostructures. J Am Chem Soc 137:6112–5.
  • Wang HB, Liu XS, Wang Y, et al. (2015). Doxorubicin conjugated phospholipid prodrugs as smart nanomedicine platforms for cancer therapy. J Mater Chem B 3:3297–305.
  • Wang RE, Liu T, Wang Y, et al. (2015). An immunosuppressive antibody-drug conjugate. J Am Chem Soc 137:3229–32.
  • Wang T, Ma X, Lei Y, et al. (2016). Solid lipid nanoparticles coated with cross-linked polymeric double layer for oral delivery of curcumin. Colloids Surf B Biointerfaces 148:1–11.
  • Wang YJ, Liu D, Zheng QC, et al. (2014). Disulfide bond bridge insertion turns hydrophobic anticancer prodrugs into self-assembled nanomedicines. Nano Lett 14:5577–83.
  • Xu Y, Villalona-Calero MA. (2002). Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity. Ann Oncol 13:1841–51.
  • Yamazaki N, Kojima S, Bovin NV, et al. (2000). Endogenous lectins as targets for drug delivery. Adv Drug Deliv Rev 43:225–44.
  • Yang Y, Zhang YM, Li D, et al. (2016). Camptothecin-polysaccharide co-assembly and its controlled release. Bioconjug Chem 27:2834–8.
  • Ye D, Shuhendler AJ, Cui L, et al. (2014). Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo. Nat Chem 6:519–26.
  • Yu GC, Zhao XL, Zhou J, et al. (2018). Supramolecular polymer-based nanomedicine: high therapeutic performance and negligible long-term immunotoxicity. J Am Chem Soc 140:8005–19.
  • Zhang CM, Chen Z, Li WH, et al. (2020). Influences of different sugar ligands on targeted delivery of liposomes. J Drug Target 28:789–801.
  • Zheng X, Li Z, Chen L, et al. (2016). Self-assembly of porphyrin-paclitaxel conjugates into nanomedicines: enhanced cytotoxicity due to endosomal escape. Chem Asian J 11:1780–4.
  • Zhu QY, Wu BY, Zhao L. (2021). Effect of algicidal compound Nω-acetylhistamine on physiological response and algal toxins in Heterosigma Akashiwo. Ecotoxicol Environ Saf 208:111423.